Mesotrypsin, a brain trypsin, activates selectively proteinase-activated receptor-1, but not proteinase-activated receptor-2, in rat astrocytes

Journal of Neurochemistry

Volumn 99, Issue 3, 2006, Pages 759-769

  Wang, Yingfei ^a   Luo, Weibo ^a   Wartmann, Thomas ^a   Halangk, Walter ^a   Sahin Tóth, Miklós ^b   Reiser, Georg ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b BOSTON UNIVERSITY   (United States)

Author keywords

Anionic trypsin; Calcium signaling; Cationic trypsin; Mesotrypsin; Proteinase activated receptors

Indexed keywords

ALANINE; ANION; ARGININE; CALCIUM ION; CATION; HOMOARGININE; ISOENZYME; MESOTRYPSIN; PHENYLALANINE; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 1 BLOCKING AGENT; PROTEINASE ACTIVATED RECEPTOR 2; SCH 79797; SYNTHETIC PEPTIDE; SYNTHETIC THROMBIN RECEPTOR AGONIST; THROMBIN RECEPTOR ACTIVATING PEPTIDE; TRYPSIN; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTOMA CELL; CALCIUM MOBILIZATION; CELL LINE; CONCENTRATION RESPONSE; ENZYME ACTIVITY; GENE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PRSS3 GENE; RAT; RAT STRAIN; RECEPTOR INTRINSIC ACTIVITY; RETINA GANGLION CELL; SPECIES DIFFERENCE;

ANIMALS; ANIMALS, NEWBORN; ASTROCYTES; BRAIN CHEMISTRY; CALCIUM; CELLS, CULTURED; CYTOSOL; ISOENZYMES; PYRROLES; QUINAZOLINES; RATS; RECEPTOR, PAR-1; RECEPTOR, PAR-2; RECOMBINANT PROTEINS; RETINAL GANGLION CELLS; TRYPSIN;

EID: 33750077249     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2006.04105.x     Document Type: Article

References (37)

1. Böhm S. K., Kong W., Bromme D., et al. (1996) Molecular cloning, expression and potential functions of the human proteinase-activated receptor-2. Biochem. J. 314, 1009-1016.
2. Chen J. M., Audrezet M. P., Mercier B., Quere I. and Ferec C. (1999) Exclusion of anionic trypsinogen and mesotrypsinogen involvement in hereditary pancreatitis without cationic trypsinogen gene mutations. Scand. J. Gastroenterol. 34, 831-832.
3. Compton S. J., Renaux B., Wijesuriya S. J. and Hollenberg M. D. (2001) Glycosylation and the activation of proteinase-activated receptor 2 (PAR 2) by human mast cell tryptase. Br. J. Pharmacol. 134, 705-718.
4. Compton S. J., McGuire J. J., Saifeddine M. and Hollenberg M. D. (2002a) Restricted ability of human mast cell tryptase to activate proteinase-activated receptor-2 in rat aorta. Can. J. Physiol. Pharmacol. 80, 987-992.
5. Compton S. J., Sandhu S., Wijesuriya S. J. and Hollenberg M. D. (2002b) Glycosylation of human proteinase-activated receptor-2 (hPAR2): role in cell surface expression and signalling. Biochem. J. 368, 495-505.
6. Cottrell G. S., Amadesi S., Grady E. F. and Bunnett N. W. (2004) Trypsin IV: a novel agonist of protease-activated receptors 2 and 4. J. Biol. Chem. 279, 13 532-13 539.
7. Dömötör E., Bartha K., Machovich R. and Adam-Vizi V. (2002) Protease-activated receptor-2 (PAR-2) in brain microvascular endothelium and its regulation by plasmin and elastase. J. Neurochem. 80, 746-754.
8. Fukuoka S. and Nyaruhucha C. M. (2002) Expression and functional analysis of rat P23, a gut hormone-inducible isoform of trypsin, reveals its resistance to proteinaceous trypsin inhibitors. Biochim. Biophys. Acta. 1588, 106-112.
9. Grishina Z., Ostrowska E., Halangk W., Sahin-Tóth M. and Reiser G. (2005) Activity of recombinant trypsin isoforms on human proteinase-activated receptors (PAR): mesotrypsin cannot activate epithelial PAR-1-2, but weakly activates brain PAR-1. Br. J. Pharmacol. 146, 990-999.
10. Hamprecht B. and Löffler F. (1985) Primary glial cultures as a model for studying hormone action. Methods Enzymol. 109, 341-345.
11. Hara H. and Shiota H. (2004) Differential increases in syntheses of newly identified trypsinogen 2 isoforms by dietary protein in rat pancreas. Exp. Biol. Med. (Maywood) 229, 772-780.
12. Katona G., Berglund G. I., Hajdu J., Gráf L. and Szilágyi L. (2002) Crystal structure reveals basis for the inhibitor resistance of human brain trypsin. J. Mol. Biol. 315, 1209-1218.
13. Kukor Z., Tóth M. and Sahin-Tóth M. (2003) Human anionic trypsinogen: properties of autocatalytic activation and degradation and implications in pancreatic diseases. Eur. J. Biochem. 270, 2047-2058.
14. Luo W., Wang Y. and Reiser G. (2005) Two types of protease-activated receptors (PAR-1 and PAR-2) mediate calcium signaling in rat retinal ganglion cells RGC-5. Brain Res. 1047, 159-167.
15. Minn A., Schubert M., Neiss W. F. and Müller-Hill B. (1998) Enhanced GFAP expression in astrocytes of transgenic mice expressing the human brain-specific trypsinogen IV. Glia 22, 338-347.
16. Nakanishi-Matsui M., Zheng Y. W., Sulciner D. J., Weiss E. J., Ludeman M. J. and Coughlin S. R. (2000) PAR3 is a cofactor for PAR4 activation by thrombin. Nature 404, 609-613.
17. Nemoda Z., Teich N., Hugenberg C. and Sahin-Tóth M. (2005) Genetic and biochemical characterization of the E32del polymorphism in human mesotrypsinogen. Pancreatology 5, 273-278.
18. Nicole O., Goldshmidt A., Hamill C. E., Sorensen S. D., Sastre A., Lyuboslavsky P., Hepler J. R., McKeon R. J. and Traynelis S. F. (2005) Activation of protease-activated receptor-1 triggers astrogliosis after brain injury. J. Neurosci. 25, 4319-4329.
19. Nyaruhucha C. N., Kito M. and Fukuoka S. I. (1997) Identification and expression of the cDNA-encoding human mesotrypsin (ogen), an isoform of trypsin with inhibitor resistance. J. Biol. Chem. 272, 10 573-10 578.
20. Nystedt S., Emilsson K., Larsson A. K., Strombeck B. and Sundelin J. (1995) Molecular cloning and functional expression of the gene encoding the human proteinase-activated receptor 2. Eur. J. Biochem. 232, 84-89.
21. Rinderknecht H., Renner I. G., Abramson S. B. and Carmack C. (1984) Mesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluid. Gastroenterology 86, 681-692.
22. Sahin-Tóth M. (2000) Human cationic trypsinogen. Role of Asn-21 in zymogen activation and implications in hereditary pancreatitis. J. Biol. Chem. 275, 22 750-22 755.
23. Sahin-Tóth M. (2005) Human mesotrypsin defies natural trypsin inhibitors: from passive resistance to active destruction. Protein Pept. Lett. 12, 457-464.
24. Scheele G., Pash J. and Bieger W. (1981) Identification of proteins according to biological activity following separation by two-dimensional isoelectric focusing/sodium dodecyl sulfate gel electrophoresis: analysis of human exocrine pancreatic proteins. Anal. Biochem. 112, 304-313.
25. Striggow F., Riek M., Breder J., Henrich Noack P., Reymann K. G. and Reiser G. (2000) The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations. Proc. Natl Acad. Sci. USA 97, 2264-2269.
26. Striggow F., Riek-Burchardt M., Kiesel A., Schmidt W., Henrich-Noack P., Breder J., Krug M., Reymann K. G. and Reiser G. (2001) Four different types of protease-activated receptors are widely expressed in the brain and are up-regulated in hippocampus by severe ischemia. Eur. J. Neurosci. 14, 595-608.
27. Suo Z., Wu M., Ameenuddin S., Anderson H. E., Zoloty J. E., Citron B. A., Andrade-Gordon P. and Festoff B. W. (2002) Participation of protease-activated receptor-1 in thrombin-induced microglial activation. J. Neurochem. 80, 655-666.
28. Szmola R., Kukor Z. and Sahin-Tóth M. (2003) Human mesotrypsin is a unique digestive protease specialized for the degradation of trypsin inhibitors. J. Biol. Chem. 278, 48 580-48 589.
29. Ubl J. J. and Reiser G. (1997) Characteristics of thrombin-induced calcium signals in rat astrocytes. Glia 21, 361-369.
30. 2+-sensitive tyrosine kinase Pyk2 and Src in thrombin signalling in rat astrocytes. J. Neurochem. 84, 1349-1357.
31. Wang H., Ubl J. J. and Reiser G. (2002a) Four subtypes of protease-activated receptors, co-expressed in rat astrocytes, evoke different physiological signaling. Glia 37, 53-63.
32. Wang H., Ubl J. J., Stricker R. and Reiser G. (2002b) Thrombin (PAR-1)-induced proliferation in astrocytes via MAPK involves multiple signaling pathways. Am. J. Physiol. Cell. Physiol. 283, C1351-C1364.
33. Wang Y., Richter-Landsberg C. and Reiser G. (2004) Expression of protease-activated receptors (PARs) in OLN-93 oligodendroglial cells and mechanism of PAR-1-induced calcium signaling. Neuroscience 126, 69-82.
34. Wang Y., Luo W., Stricker R. and Reiser G. (2006) Protease-activated receptor-1 protects rat astrocytes from apoptotic cell death via JNK-mediated release of the chemokine GRO/CINC-1. J. Neurochem 98, 1046-1060.
35. Wiegand U., Corbach S., Minn A., Kang J. and Müller-Hill B. (1993) Cloning of the cDNA encoding human brain trypsinogen and characterization of its product. Gene 136, 167-175.
36. Xi G., Reiser G. and Keep R. F. (2003) The role of thrombin and thrombin receptors in ischemic, hemorrhagic and traumatic brain injury: deleterious or protective? J. Neurochem. 84, 3-9.
37. Xu W. F., Andersen H., Whitmore T. E., Presnell S. R., Yee D. P., Ching A., Gilbert T., Davie E. W. and Foster D. C. (1998) Cloning and characterization of human protease-activated receptor 4. Proc. Natl Acad. Sci. USA 95, 6642-6646.